Several ASX-listed companies are undertaking phase III clinical trials, the critical final stage before potential regulatory ...

The FDA has approved 2 additional vial sizes of Niktimvo™ (axatilimab-csfr), 9mg/0.18mL and 22mg/0.44mL, in addition to the 50mg/mL size.

Cullinan Therapeutics has announced that its lead asset has aced a midstage lung cancer trial—but the biotech is keeping the ...

XOMA Royalty Corp (NASDAQ:XOMA), a $313 million market cap company, experienced a significant stock sale as reported in a recent SEC filing. Several major investors, including BVF Partners L.P., ...

First-line maintenance (1LM) niraparib significantly extends progression-free survival (rwPFS) and time to next treatment ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

University of Kentucky Markey Cancer Center researchers have discovered a promising new way to combat therapy-resistant ...

A multicenter collaboration has identified a potential new treatment for an aggressive sarcoma arising in the nerves. The ...

The Sailors earn a 2-0 win over the visiting Sea Kings on Friday to remain in contention for a playoff spot out of the Sunset League. Anthony Rodolfo Samayoa, 20, was arrested on suspicion of DUI ...

Javid laid out priorities for transformation in healthcare, including a push for more personalised care and "making big breakthrough bets on emerging technologies and data." Greater use of NHS app ...

The field of cancer treatment is witnessing rapid advancements due to progress in proteomics, genomics, and drug discovery. These technologies have ...